Health Condition 1: K056- Periodontal disease, unspecified
Conditions
Interventions
Intervention1: Ketorolac tromethamine with Benzydamine hydrochloride mouthwash: Ketorolac tromethamine is a Non-selective COX Inhibitor which has analgesic and anti-inflammatory properties which works
Sponsors
Dr Sarvapradha S S
Eligibility
Inclusion criteria
Inclusion criteria: Systemically healthy patient Patient age ranging 30-60 years Periodontal pocket depth more than or equal to 5mm Patients with good oral hygiene after scaling and root planning Patient who have agreed to participate in the study
Exclusion criteria
Exclusion criteria: The patients who are undergoing treatment with analgesics or corticosteroids during the trial period Pregnancy and lactating mothers Smokers and alcoholic Patients who require resective osseous surgery and regenerative osseous surgery. Patients with cardiovascular disease and stroke Patients with gastrointestinal bleeding or ulcers Patients with liver disease Patients with kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Ketorolac tromethamine and benzydamine hydrocholride mouthwash in reducing postoperative pain and promoting wound healing. To assess the efficacy of Ketorolac tromethamine in reducing postoperative pain and promoting wound healing. To evaluate the efficacy of Etoricoxib and Benzydamine hydrochloride mouthwash in reducing postoperative pain and promoting wound healing. To assess the efficacy of Etoricoxib in reducing postoperative pain and promoting wound healing. Timepoint: Follow up-1day,3days and 7days | — |
Secondary
| Measure | Time frame |
|---|---|
| • To analyze and compare the effect of Ketorolac tromethamine and Etoricoxib with and without Benzydamine Hydrochloride mouthwash in management of postoperative pain and promoting wound healing.Timepoint: Follow up- 1day, 3days and 7 days | — |
Countries
India
Contacts
Public ContactDr Prakash Pai G
KVG Dental College and Hospital
Outcome results
None listed